You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is A 50-year-old female with rheumatoid ahritis is being considered for infliximab therapy. Which of the following tests should be performed before beginning treatment? and explain in detail?
Infliximab is a monoclonal antibody targeting TNF-a. It is commonly used to treat moderate to severe rheumatoid ahritis paicularly in patients who do not respond to methotrexate therapy. TNF-a inhibitors can lead to reactivation of latent tuberculosis due to TNF-a inhibitor action. All patients being considered for TNF-a inhibitor therapy should therefore have a baseline PPD skin test to screen for latent tuberculosis.